AI Article Synopsis
- - The report presents mid-season vaccine effectiveness (VE) estimates for the 2019-2020 influenza season, focusing on data from military personnel and civilians at the U.S.-Mexico border as collaborated by various health surveillance programs.
- - Among active service members, the vaccine showed low to moderate effectiveness against different strains: low protection against overall influenza A and A(H1N1), moderate protection against A(H3N2), and low to moderate protection against influenza B.
- - In contrast, the analyses for DoD beneficiaries and U.S.-Mexico border civilians revealed statistically significant moderate protection against all strains tested, including influenza A overall and both A(H1N1) and A(H3N2).
Article Abstract
This report provides mid-season vaccine effectiveness (VE) estimates from the Armed Forces Health Surveillance Division (AFHSD), the DoD Global Respiratory Pathogen Surveillance (DoDGRS) program, and the Naval Health Research Center (NHRC) for the 2019-2020 influenza season. Using a test negative case-control study design, the AFHSD performed a VE analysis for active component service members while the DoDGRS program and NHRC collaborated to perform a VE analysis for DoD beneficiaries and U.S.-Mexico border civilians. Among active component service members, there was low to moderate protection against influenza B, moderate protection against A(H3N2), and non-statistically significant low protection against influenza A overall and A(H1N1). Among DoD beneficiaries and U.S.-Mexico border civilians, there was statistically significant moderate protection against influenza B, influenza A overall, A(H1N1), and A(H3N2).
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!